NASDAQ
20.12.24
21:59 Uhr
52,70 US-Dollar
0,00
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| TARSUS PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| Do | Tarsus Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 11.12. | Tarsus Pharmaceuticals Stock Hits 52-Week High at $53.02 | 2 | Investing.com | ||
| 13.11. | Tarsus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.31, revenue of $48.1M beats by $4.92M | 1 | Seeking Alpha | ||
| 13.11. | Tarsus Pharmaceuticals, Inc: Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements | 121 | GlobeNewswire (Europe) | Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter Strengthened payer coverage highlighted by securing the two remaining... ► Artikel lesen | |
| 13.11. | Tarsus Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | Tarsus Pharmaceuticals, Inc: Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors | 3 | GlobeNewswire (USA) | ||
| 12.11. | Earnings Outlook For Tarsus Pharmaceuticals | 3 | Benzinga.com | ||
| 06.11. | Tarsus Pharmaceuticals, Inc: Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 | 2 | GlobeNewswire (USA) | ||
| 06.11. | Tarsus Pharmaceuticals seesaws amid report Alcon interest has cooled | 6 | Seeking Alpha | ||
| 06.11. | Tarsus Pharmaceuticals-Aktie erreicht 52-Wochen-Hoch bei 48,65 US-Dollar | 2 | Investing.com Deutsch | ||
| 06.11. | Tarsus Pharmaceuticals stock hits 52-week high at $48.65 | 1 | Investing.com | ||
| 05.11. | Tarsus Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.11. | Tarsus appoints Elizabeth Yeu as its Chief Medical Officer | 1 | Seeking Alpha | ||
| 05.11. | Tarsus Pharmaceuticals, Inc: Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer | 90 | GlobeNewswire (Europe) | IRVINE, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to address unmet medical needs and apply proven science and new technology to revolutionize... ► Artikel lesen | |
| 29.10. | Tarsus Pharmaceuticals stock hits 52-week high at $42.63 | 2 | Investing.com | ||
| 29.10. | Tarsus Pharmaceuticals gains amid takeover speculation | 13 | Seeking Alpha | ||
| 22.10. | Oppenheimer hält an Kursziel und Outperform-Rating für Tarsus trotz Umsatzprognose fest | 4 | Investing.com Deutsch | ||
| 22.10. | Oppenheimer retains stock target, outperform on Tarsus amid sales projection | 1 | Investing.com | ||
| 17.10. | Tarsus taps actor Betsy Sodaro to embody a 'mitey problem' in 1st Xdemvy DTC TV ad | 3 | FiercePharma | ||
| 17.10. | Tarsus Pharmaceuticals, Inc: Tarsus Launches "Your Mitey Problem," the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EPIGENOMICS | 1,150 | +3,60 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,402 | +10,14 % | Defence Therapeutics Inc.: Defence Announces Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Its Board of Directors | Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company... ► Artikel lesen | |
| GINKGO BIOWORKS | 10,300 | +6,19 % | Ginkgo Bioworks eligible for $9.4M in partnership for bioelectronic devices | ||
| PHIO PHARMACEUTICALS | 2,370 | +36,99 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces $1.15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Marlborough, Massachusetts--(Newsfile Corp. - December 19, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL® siRNA... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 7,220 | +2,09 % | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | SAN CARLOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 6,275 | +3,98 % | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug... ► Artikel lesen | |
| BEAM THERAPEUTICS | 29,230 | +0,79 % | Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology ... |
NHP Data Showed CD117 Monoclonal Antibody (mAb) Conditioning Successfully Achieved Long-term Engraftment of Base-edited Hematopoietic Stem Cells and Induced Robust Levels of Hemoglobin F mAb Dosing... ► Artikel lesen | |
| ROCKET PHARMACEUTICALS | 11,235 | +1,31 % | Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy' | ||
| ONCOLYTICS BIOTECH | 0,730 | 0,00 % | Oncolytics Biotech Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data | ||
| ARCTURUS THERAPEUTICS | 15,490 | -0,06 % | Arcturus Therapeutics Holdings Inc.: Arcturus Therapeutics to Present at Jefferies London Healthcare Conference | Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities... ► Artikel lesen | |
| ASSERTIO | 0,880 | -1,26 % | Assertio Holdings, Inc. - 8-K, Current Report | ||
| ADMA BIOLOGICS | 17,520 | +0,69 % | ADMA Biologics, Inc.: ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility | ||
| SIGA TECHNOLOGIES | 5,920 | -0,17 % | SIGA Technologies Inc.: Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced | Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy stopped enrolling patients in all study armsResults... ► Artikel lesen | |
| VIR BIOTECHNOLOGY | 7,370 | +0,41 % | Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update | SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ended September 30, 2024.
"This quarter... ► Artikel lesen | |
| TRAVERE THERAPEUTICS | 16,400 | -0,61 % | Travere Therapeutics, Inc.: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on November 10, 2024, the Compensation Committee of its Board of Directors granted inducement... ► Artikel lesen |
Das Unternehmen TARSUS PHARMACEUTICALS INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,00 (0,00 %) liegt der Kurs bei 52,70 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TARSUS PHARMACEUTICALS INC finden Sie auf Wallstreet Online.
